ArticleJournal of family medicine and primary care2025
Seroprevalence of hepatitis D virus infection among hepatitis B virus-infected patients attending UPUMS, Saifai: A cross-sectional study.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: HDV is a defective RNA virus that requires HBV for the replication; therefore, HDV can only get transmitted to the people who also have HBV infection and lead severe liver disease. Globally, the geographical distribution of HDV infection among HBV-positive people is very heterogeneous. In India, limited data are available on prevalence of HDV among hepatitis B surface antigen (HBsAg)-positive patients. In our state, Uttar Pradesh, or region, there is lack of data on seroprevalence of HDV infection. Aim: The aim of our study was to determine the seroprevalence of HDV infection among HBsAg-positive cases. Methods and Material: This hospital-based cross-sectional study was carried out in the Department of Microbiology. 87 HBsAg-positive samples were included in the study. HBsAg-positive samples were subjected to anti HDV IgM and IgG ELISA Kit by Elabscience Results: The mean age of HBsAg-positive patients was 36.6 years (SD: 14.6), with a male: female ratio of 2:1. Out of 87 HBsAg-positive patients, serological evidence of delta virus infection was observed in 6 patients (6.8%); 4 (4.6%) patients were positive for anti HDV IgG antibodies, and 2 (2.3%) were positive for anti HDV IgM antibodies. Conclusions: This study provides evidence that seroprevalence of HDV coinfection in the case of Hepatitis B is low (6.8%) in the western part of Uttar Pradesh; understanding the seroprevalence of Hepatitis D helps public health authorities to allocate resources effectively and design target interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.